Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,410,581 | 4,410,581 | 0 | $69.25M | $77.63M | 62.70% | +$8.38M |
| Maze Therapeutics, Inc.(MAZE) | 2,111,919 | 2,111,919 | 0 | $23.25M | $25.91M | 20.93% | +$2.66M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 800,399 | +800,399 | $0 | $7.08M | 5.72% | +$7.08M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 160,000 | +160,000 | $0 | $5.01M | 4.05% | +$5.01M |
| Kura Oncology, Inc.(KURA) | 1,111,882 | 816,882 | -295,000 | $7.34M | $4.71M | 3.81% | -$2.63M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | $2.62M | $3.46M | 2.79% | +$840.0K |
| Lyell Immunopharma, Inc.(LYEL) | 16,007,999 | 0 | -16,007,999 | $8.61M | $0 | — | -$8.61M |